Skip to content
Home/Companies/Healthcare/DNA Diagnostics Center

DNA Diagnostics Center

Healthcare·United States·Exited 2021·Held 6yr
Entry
2015
Hold
6yr
Exit
2021

Who owns DNA Diagnostics Center?

DNA Diagnostics Center is an American Healthcare company, now owned by Eurofins, which acquired it in 2021 from GHO Capital.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
GHO Capital
Investor
GHO Capital
GHO Capital Fund I LP · 2015 · Buyout

Key facts

HQUnited States
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
Eurofins
Exit Year
2021

More from GHO Capital Fund I LP

Other portfolio companies in the same fund.

BioAgilytix
Exited 2021
BiotechUS· 2018
to Cinven
Linimed-Fazmed
Active
HealthcareGermany· 2018
Caprion Biosciences
Exited 2019
BiotechCanada· 2016
to Arsenal Capital Partners
VISUfarma
VISUfarma
Exited 2026
PharmaUK· 2016
to Lupin
Quotient Clinical
Active
PharmaUK· 2015
Quotient Sciences
Exited 2019
PharmaUK· 2015
to Permira

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns DNA Diagnostics Center?

DNA Diagnostics Center is now owned by Eurofins, which acquired it in 2021 from GHO Capital.

When did Eurofins acquire DNA Diagnostics Center?

Eurofins acquired DNA Diagnostics Center in 2021, buying from GHO Capital.

Who did DNA Diagnostics Center sell to?

GHO Capital sold DNA Diagnostics Center to Eurofins in 2021 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue